GabrielP.HaasMD

Surgical Oncology

Gabriel P. Haas, MD, FACS was President of the HMAA in 2004-2006. He is Clinical Professor of Urology at Loyola University School of Medicine and Medical Director for Astellas Pharma Global Medical Affairs.

Join to view full profile

Dr. Haas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haas' full profile

Already have an account?

Office
750 E Adams St
Syracuse, NY 13210
Phone+1 315-464-6106

Education & Training

Henry Ford Health/Henry Ford HospitalResidency, Urology, 1982 - 1987
Wayne State University School of MedicineClass of 1982

Certifications & Licensure

MI State Medical License 1983 - 2026
NY State Medical License 1995 - 2026
American Board of Urology Urology

Publications & Presentations

PubMed

60 citations
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Stephen J Freedland, Murilo de Almeida Luz, Ugo De Giorgi, Martin Gleave, Geoffrey T Gotto
The New England Journal of Medicine. 2023-10-19
25 citations
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
Andrew J. Armstrong, Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein
The Journal of Urology. 2021-05-01
Reply by Authors.
Andrew J Armstrong, Neal D Shore, Russell Z Szmulewitz, Daniel P Petrylak, Jeffrey Holzbeierlein
The Journal of Urology. 2021-05-01

GabrielP.HaasMD

Dr. Haas is on Doximity

Education & Training

Certifications & Licensure

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.